Utilization of pre-operative imaging for colon cancer: A population-based study

2016 ◽  
Vol 115 (2) ◽  
pp. 202-207
Author(s):  
Matthew D.F. McInnes ◽  
Sulaiman Nanji ◽  
William J. Mackillop ◽  
Jennifer A. Flemming ◽  
Xuejiao Wei ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Population Based ◽  
Population Based Study

Oncological outcomes after complete mesocolic excision in right‐sided colon cancer: a population‐based study

2021 ◽  
Author(s):  
Richard Bernhoff ◽  
Annika Sjövall ◽  
Fredrik Granath ◽  
Torbjörn Holm ◽  
Anna Martling ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Complete Mesocolic Excision ◽  
Population Based ◽  
Population Based Study ◽  
Oncological Outcomes ◽  
Mesocolic Excision

scholarly journals Chemotherapy of metastatic colon cancer in France: A population-based study

2021 ◽  
Author(s):  
Léo Mas ◽  
Jean-Baptiste Bachet ◽  
Valérie Jooste ◽  
Côme Lepage ◽  
Anne-Marie Bouvier
Keyword(s):  
Colon Cancer ◽  
Population Based ◽  
Metastatic Colon Cancer ◽  
Population Based Study

scholarly journals Conditional Survival and Cure of Patients With Colon or Rectal Cancer: A Population-Based Study

2020 ◽  
Vol 18 (9) ◽  
pp. 1230-1237 ◽  
Author(s):  
Seyed M. Qaderi ◽  
Paul W. Dickman ◽  
Johannes H.W. de Wilt ◽  
Rob H.A. Verhoeven
Keyword(s):  
Rectal Cancer ◽  
Colon Cancer ◽  
Population Based ◽  
Stage I ◽  
Stage Iii ◽  
Disease Stage ◽  
Conditional Survival ◽  
Population Based Study ◽  
Pathologic Stage ◽  
Number Of Patients

Background: The increasing number of colorectal cancer (CRC) survivors need survival estimates that account for the time already survived. The aim of this population-based study was to determine conditional survival, cure proportions, and time-to-cure (TTC) of patients with colon or rectal cancer. Materials and Methods: All patients with pathologic stage I–III CRC treated with endoscopy or surgery, diagnosed and registered in the Netherlands Cancer Registry between 1995 and 2016, and aged 18 to 99 years were included. Conditional survival was calculated for those diagnosed before and after 2007. Cure proportions were calculated using flexible parametric models. Results: A total of 175,384 patients with pathologic stage I (25%), II (38%), or III disease (37%) were included. Conditional 5-year survival of patients with stage I, II, and III colon cancer having survived 5 years was 98%, 94%, and 92%, respectively. For patients with stage I–III rectal cancer, this was 96%, 89%, and 85%, respectively. Statistical cure in patients with colon cancer was reached directly after diagnosis (stage I) to 6 years (stage III) after diagnosis depending on age, sex, and disease stage. Patients with rectal cancer reached cure 0.5 years after diagnosis (stage I) to 9 years after diagnosis (stage III). In 1995, approximately 42% to 46% of patients with stage III colon or rectal cancer, respectively, were considered cured, whereas in 2016 this percentage increased to 73% to 78%, respectively. Conclusions: The number of patients with CRC reaching cure has increased substantially over the years. This study’s results provide valuable insights into trends of CRC patient survival and are important for patients, clinicians, and policymakers.

Evaluation of Lymph Nodes in Patients with Colon Cancer Undergoing Colon Resection: A Population-based Study

2012 ◽  
Vol 36 (8) ◽  
pp. 1906-1914 ◽  
Author(s):  
Yun-Jau Chang ◽  
Yao-Jen Chang ◽  
Li-Ju Chen ◽  
Kuo-Piao Chung ◽  
Mei-Shu Lai
Keyword(s):  
Colon Cancer ◽  
Lymph Nodes ◽  
Population Based ◽  
Colon Resection ◽  
Population Based Study

Prognostic relevance of microsatellite instability in pT3N0M0 colon cancer: a population-based study

2015 ◽  
Vol 11 (1) ◽  
pp. 41-46 ◽  
Author(s):  
Francesco Iachetta ◽  
Federica Domati ◽  
Luca Reggiani-Bonetti ◽  
Valeria Barresi ◽  
Giulia Magnani ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Microsatellite Instability ◽  
Population Based ◽  
Population Based Study ◽  
Prognostic Relevance
Sign in / Sign up

Export Citation Format

Share Document